These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4479374)

  • 21. Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists.
    Chase TN
    Arch Neurol; 1973 Nov; 29(5):349-51. PubMed ID: 4270339
    [No Abstract]   [Full Text] [Related]  

  • 22. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564
    [No Abstract]   [Full Text] [Related]  

  • 23. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
    Altamura AC; Buccio M; Colacurcio F; Colombo G; Terzi A
    Acta Neurol (Napoli); 1986 Feb; 8(1):19-26. PubMed ID: 3962752
    [No Abstract]   [Full Text] [Related]  

  • 24. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics.
    Van Praag HM; Korf J
    Am J Psychiatry; 1976 Oct; 133(10):1171-7. PubMed ID: 970488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
    Mayeux R
    Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.
    van Kammen DP; Kelley ME; Gurklis JA; Gilbertson MW; Yao JK; Peters JL
    Arch Gen Psychiatry; 1995 Aug; 52(8):673-8. PubMed ID: 7543265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
    Fujimoto A
    Seishin Shinkeigaku Zasshi; 1980; 82(5):275-91. PubMed ID: 6157171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Homovanillic acid (HVA) and gamma-aminobutyric acid (GABA) levels in the cerebrospinal fluid of patients with extrapyramidal syndromes].
    Smiałek M; Królikiewicz-Sciborowska H; Skrobisz MD; Niemczewska-Syropolska M; Sasinowska M
    Neuropatol Pol; 1986; 24(4):585-602. PubMed ID: 3587659
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of fenfluramine in Huntington Chorea].
    Roccatagliata G; Pizio N; Farinini D; Firpo MP; Bartolini A; Bacigalupo F; Albano C
    Rev Neurol (Paris); 1983; 139(10):589-92. PubMed ID: 6196830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
    Petursson H; Bond PA; Smith B; Lader MH
    Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study.
    Zarifian E; Scatton B; Bianchetti G; Cuche H; Loo H; Morselli PL
    Arch Gen Psychiatry; 1982 Feb; 39(2):212-5. PubMed ID: 7065833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Letter: Narcolepsy. Suppression of paradoxical sleep by L-dopa].
    Gilbert JC; Willer JC; Bernheim-Chatelain C; Ecoffet M; Jaillon P
    Nouv Presse Med; 1976 May; 5(20):1309-10. PubMed ID: 180496
    [No Abstract]   [Full Text] [Related]  

  • 35. Catecholamine and serotonin content of foods: effect on urinary excretion of homovanillic and 5-hydroxyindoleacetic acid.
    Feldman JM; Lee EM; Castleberry CA
    J Am Diet Assoc; 1987 Aug; 87(8):1031-5. PubMed ID: 2440934
    [No Abstract]   [Full Text] [Related]  

  • 36. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes].
    Barkhatova VP; Kandel' EI; Omorova TM; Demina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1050-5. PubMed ID: 6382885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of extrapyramidal side effects of haloperidol through the joint use of imipramine-type drugs.
    Butterworth AT
    Psychosomatics; 1972; 13(5):328-32. PubMed ID: 4671924
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
    Goff DC; Midha KK; Brotman AW; Waites M; Baldessarini RJ
    Am J Psychiatry; 1991 Jun; 148(6):790-2. PubMed ID: 2035723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.
    Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1979; 227(3):181-92. PubMed ID: 94992
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.